Intelligence · Clinical pipeline
Phase II Pipeline Programs
Proof-of-concept and dose-finding clinical programs in Phase II development.
Quick answer
NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.
Top sponsors
- Chinese Academy of 432 programs
- BRIGHT MINDS BIOSCIENCES 393 programs
- First People's Hospital 375 programs
- United Therapeutics Europe 336 programs
- Takeda 335 programs
- Anaxis Pharma 223 programs
- George Institute for 187 programs
- Regeneron UK 176 programs
- Teva Pharma 126 programs
- Novartis India 121 programs
- Telethon Foundation 119 programs
- Disc Medicine 106 programs
Pipeline programs
-
Marine active
Xiyuan Hospital of China Academy of Chinese Medical Sciences
"Hyperuricemia,Anserine"
1 trial -
Match placebo to test product, Balinatunfib
Sanofi-aventis Healthcare Pty Ltd
Crohn's disease
1 trial -
Matched Placebo
Novo Nordisk A/S
Mechanical allodynia
1 trial -
Matched placebo for test product, Itepekimab
Sanofi-aventis Healthcare Pty Ltd
Respiratory tract diseases
1 trial -
Matched placebo for test product, SAR444336
Sanofi-aventis Healthcare Pty Ltd
Digestive system diseases
1 trial -
Matched, SAR444656
Sanofi-aventis Healthcare Pty Ltd
Dermatitis atopic
1 trial -
Matches test product
Bioprojet Pharma
Essential tremor
1 trial -
Matches test product
Bioprojet Pharma
Primary premature ejaculation
1 trial -
Matching Placebo
Cyclerion Therapeutics
Diabetes Mellitus, Type 2
1 trial -
Matching film-coated placebo tablet
Bioprojet Pharma
Obsessive compulsive disorder
1 trial -
Matching orodispersible placebo tablet
Bioprojet Pharma
Eosinophilic esophagitis
1 trial -
Matching placebo
BRIGHT MINDS BIOSCIENCES INC.
Familial Dysautonomia
1 trial -
Mavodelpar
OnKure Therapeutics
Primary Mitochondrial Myopathy
1 trial -
Mavrilimumab
Kiniksa Pharmaceuticals International, plc
COVID-19
3 trials -
Mazindol
BRIGHT MINDS BIOSCIENCES INC.
Cocaine-Related Disorders
1 trial -
Mebendazole
Krystal Biotech Netherlands B.V.
Pilomyxoid Astrocytoma
1 trial -
Mecasermin rinfabate
Wuhan Createrna Science and Technology Co., Ltd
Chronic Lung Disease
1 trial -
Medical Collagen Membrane with MSC
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Wounds
1 trial -
Medtronic PrimeADVANCED Neurostimulator
Rhythm Pharmaceuticals Netherlands B.V.
Heart Failure
1 trial -
Mekinist 0.5 mg film-coated tablets
Disc Medicine
Neurofibromatosis type 1
1 trial -
Mektovi film-coated tablets for metastatic colorectal cancer wi…
Disc Medicine
metastatic colorectal cancer with a proven RAS mutation after failure of standard systemic treatment regimens including at least 5- FU/capecitabine-oxaliplatin and irinotecan based standard treatment (unless contra-indications for either oxaliplatin or irinotecan)
1 trial -
Melperone HCl
Lundbeck Australia Pty Ltd
Parkinson's Disease
1 trial -
Melphalan
Takeda
Multiple Myeloma
1 trial -
Melphalan
Ultragenyx UK Limited
Amyloidosis
1 trial -
Melphalan flufenamide (Melflufen)
Chongqing Precision Biotech Co., Ltd
Multiple Myeloma
1 trial -
Memantine
BRIGHT MINDS BIOSCIENCES INC.
Cocaine-Related Disorders
1 trial -
Memantine Oral Tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation Disease
1 trial -
Memory Flexibility Training
COGNITION THERAPEUTICS INC
Major Depressive Disorder
1 trial -
MenSCs transplantation
The First People's Hospital of Lianyungang
Type 1 Diabetes Mellitus
1 trial -
Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine (adjuvant-free)
BRIGHT MINDS BIOSCIENCES INC.
Meningitis
1 trial -
Menstrual blood stem cells
The First People's Hospital of Lianyungang
Acute Lung Injury
1 trial -
Merimepodib
Vertex Pharmaceuticals (Australia) Pty.
Hepatitis C
1 trial -
Meropenem-Vaborbactam
Lacuna Pharma Pty Ltd
Complicated Urinary Tract Infection (cUTI), Acute Pyelonephritis (AP)
1 trial -
Mesenchymal Stromal Cells
United Therapeutics Europe Ltd
Corneal Ulcer
1 trial -
Mesenchymal progenitor cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Knee Osteoarthritis
1 trial -
Mesenchymal stem cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hematopoietic Stem Cell Transplantation
1 trial -
Mesenchymal stem cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Graft-versus-host Disease
1 trial -
Mesenchymal stem cells for Systemic Sclerosis
Disc Medicine
Systemic Sclerosis
1 trial -
Mesenchymal stem cells from adipose tissue
Lxo Ireland Designated Activity Company
Critical Limb Ischemia
1 trial -
Metformin
United Therapeutics Europe Ltd
C9orf72 Amyotrophic Lateral Sclerosis (ALS)
1 trial -
Metformin
United Therapeutics Europe Ltd
Polycystic Kidney, Autosomal Dominant
1 trial -
Metformin + Standard of Care
United Therapeutics Europe Ltd
Focal Segmental Glomerulosclerosis
1 trial -
Metformin Hydrochloride ER
Atrium Therapeutics
Sarcoma Metastatic
1 trial -
Metformin Zentiva 500 mg Filmtabletten
The George Institute
Multidrug rezistant pulmonary tuberculosis
1 trial -
Methadone
BRIGHT MINDS BIOSCIENCES INC.
Cocaine-Related Disorders
1 trial -
Methamphetamine
BRIGHT MINDS BIOSCIENCES INC.
Methamphetamine Intoxication
1 trial -
Methotrexate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Primary Central Nervous System Lymphoma
1 trial -
Methotrexate tablets
The First People's Hospital of Lianyungang
Solid Tumors
1 trial
Frequently asked questions
How many Phase II pipeline programs are in the directory?
7,238 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.